Victoria Forster

“This article substantially overhypes early pre-clinical work with a viral therapy that has not yet been tested in even the earliest stages of human clinical trials. The headline is particularly misleading as I can find only three published papers suggesting the therapy has efficacy in lung, breast and colorectal cancers in cell lines and mouse models only.”